GlassScriptPhysician profile
Rakesh M Patel
NPI 1467614792
$108,436.47
in general payments reported to CMS, 2019-2025
7 companies · $5,820 in 2025
The $5,820 reported for 2025 was more than what 86% of Ophthalmic Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $299).
See the full distribution for Ophthalmic Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $1,504 · 2021: $24K · 2022: $35K · 2023: $30K · 2024: $11K · 2025: $5,820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $24K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Travel and Lodging: $6,597 · Food and Beverage: $1,819 · Consulting Fee: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $24,175.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,237.50 |
| Travel and Lodging | $6,596.52 |
| Food and Beverage | $1,818.95 |
| Consulting Fee | $850.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $90,950.40 | 2019-2023 | Tepezza |
| Amgen INC. | $16,945.05 | 2024-2025 | Tepezza |
| Merz North America, INC. | $150.41 | 2024 | |
| Biotissue Holdings INC. | $146.55 | 2024 | |
| Aerie Pharmaceuticals, INC. | $125.00 | 2021 | |
| Glaukos Corporation | $99.66 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rakesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.